ZA962711B - Use of imidazol[1,2-a]pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia - Google Patents
Use of imidazol[1,2-a]pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal gangliaInfo
- Publication number
- ZA962711B ZA962711B ZA962711A ZA962711A ZA962711B ZA 962711 B ZA962711 B ZA 962711B ZA 962711 A ZA962711 A ZA 962711A ZA 962711 A ZA962711 A ZA 962711A ZA 962711 B ZA962711 B ZA 962711B
- Authority
- ZA
- South Africa
- Prior art keywords
- imidazol
- dysfunction
- pyridine
- therapeutic treatment
- basal ganglia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95RM000223A IT1276522B1 (it) | 1995-04-07 | 1995-04-07 | Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA962711B true ZA962711B (en) | 1996-07-30 |
Family
ID=11403250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA962711A ZA962711B (en) | 1995-04-07 | 1996-04-04 | Use of imidazol[1,2-a]pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia |
Country Status (25)
Country | Link |
---|---|
US (1) | US5891891A (hu) |
EP (1) | EP0819002B1 (hu) |
JP (1) | JP4049390B2 (hu) |
KR (1) | KR100425628B1 (hu) |
CN (1) | CN1198612C (hu) |
AR (1) | AR003414A1 (hu) |
AT (1) | ATE222763T1 (hu) |
AU (1) | AU707759B2 (hu) |
CA (1) | CA2217590C (hu) |
CZ (1) | CZ292020B6 (hu) |
DE (1) | DE69623271T2 (hu) |
DK (1) | DK0819002T3 (hu) |
EA (1) | EA000396B1 (hu) |
ES (1) | ES2182967T3 (hu) |
HU (1) | HUP9900733A3 (hu) |
IL (1) | IL117824A (hu) |
IT (1) | IT1276522B1 (hu) |
MX (1) | MX9707712A (hu) |
NO (1) | NO315408B1 (hu) |
NZ (1) | NZ304107A (hu) |
PL (1) | PL322647A1 (hu) |
PT (1) | PT819002E (hu) |
TW (1) | TW450816B (hu) |
WO (1) | WO1996031210A1 (hu) |
ZA (1) | ZA962711B (hu) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7632517B2 (en) * | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
US6333345B1 (en) | 1999-05-14 | 2001-12-25 | Sepracor, Inc. | Methods of using and compositions comprising N-desmethylzolpidem |
US6399621B1 (en) | 1999-08-10 | 2002-06-04 | American Cyanamid Company | N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
US20030091632A1 (en) * | 1999-08-26 | 2003-05-15 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
US6485746B1 (en) | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
US6384221B1 (en) | 1999-09-02 | 2002-05-07 | Neurocrine Biosciences, Inc. | Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
AU5066101A (en) * | 2000-04-13 | 2001-10-30 | Synthon B.V. | Modified release formulations containing a hypnotic agent |
ATE335481T1 (de) * | 2000-04-24 | 2006-09-15 | Teva Pharma | Zolpidem hemitartrat solvat |
DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
DE10117183A1 (de) * | 2001-04-05 | 2002-10-10 | Gruenenthal Gmbh | Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel |
GB0311457D0 (en) * | 2003-05-19 | 2003-06-25 | Sciencom Ltd | New therapeutic use |
KR20060023129A (ko) | 2003-05-19 | 2006-03-13 | 사이언콤 리미티드 | 졸피뎀의 추가 치료적 사용 |
DE10334187A1 (de) * | 2003-07-26 | 2005-03-03 | Schwarz Pharma Ag | Substituierte 2-Aminotetraline zur Behandlung von Depressionen |
DE10334188B4 (de) * | 2003-07-26 | 2007-07-05 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung von Depressionen |
DK1691811T3 (da) | 2003-12-11 | 2014-10-20 | Sunovion Pharmaceuticals Inc | Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression |
DE10361258A1 (de) | 2003-12-24 | 2005-07-28 | Schwarz Pharma Ag | Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson |
WO2005079851A2 (en) | 2004-02-18 | 2005-09-01 | Sepracor, Inc. | Dopamine-agonist combination therapy with sedatives for improving sleep quality |
DE102004014841B4 (de) * | 2004-03-24 | 2006-07-06 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms |
DE602006008339D1 (en) * | 2005-11-18 | 2009-09-17 | Synhton B V | Zolpidemtabletten |
WO2008056139A2 (en) * | 2006-11-08 | 2008-05-15 | Regen Therapeutics Plc | Transdermal therapy |
GB0809936D0 (en) * | 2008-05-30 | 2008-07-09 | Regen Therapeutics Plc | Therapeutic use of zolpidem |
US11547706B2 (en) | 2016-06-08 | 2023-01-10 | President And Fellows Of Harvard College | Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, Rett syndrome, and Fragile X syndrome |
AU2019279858A1 (en) | 2018-05-29 | 2020-11-26 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2492382A1 (fr) * | 1980-10-22 | 1982-04-23 | Synthelabo | Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique |
US5032595A (en) * | 1989-11-24 | 1991-07-16 | Fidia-Georgetown Institute For The Neurosciences | Method of stimulating steroidogenesis with alpidem |
US5206382A (en) * | 1991-06-27 | 1993-04-27 | Fidia Georgetown Institute For The Neurosciences | Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders |
-
1995
- 1995-04-07 IT IT95RM000223A patent/IT1276522B1/it active IP Right Grant
-
1996
- 1996-04-02 DK DK96907656T patent/DK0819002T3/da active
- 1996-04-02 AT AT96907656T patent/ATE222763T1/de active
- 1996-04-02 MX MX9707712A patent/MX9707712A/es unknown
- 1996-04-02 PL PL96322647A patent/PL322647A1/xx unknown
- 1996-04-02 ES ES96907656T patent/ES2182967T3/es not_active Expired - Lifetime
- 1996-04-02 KR KR1019970707107A patent/KR100425628B1/ko not_active IP Right Cessation
- 1996-04-02 HU HU9900733A patent/HUP9900733A3/hu unknown
- 1996-04-02 EA EA199700308A patent/EA000396B1/ru not_active IP Right Cessation
- 1996-04-02 CN CNB961937815A patent/CN1198612C/zh not_active Expired - Fee Related
- 1996-04-02 AU AU51200/96A patent/AU707759B2/en not_active Ceased
- 1996-04-02 WO PCT/IT1996/000063 patent/WO1996031210A1/en active IP Right Grant
- 1996-04-02 EP EP96907656A patent/EP0819002B1/en not_active Expired - Lifetime
- 1996-04-02 DE DE69623271T patent/DE69623271T2/de not_active Expired - Lifetime
- 1996-04-02 CA CA002217590A patent/CA2217590C/en not_active Expired - Lifetime
- 1996-04-02 NZ NZ304107A patent/NZ304107A/xx not_active IP Right Cessation
- 1996-04-02 US US08/930,644 patent/US5891891A/en not_active Expired - Lifetime
- 1996-04-02 JP JP53016596A patent/JP4049390B2/ja not_active Expired - Fee Related
- 1996-04-02 CZ CZ19973167A patent/CZ292020B6/cs not_active IP Right Cessation
- 1996-04-02 PT PT96907656T patent/PT819002E/pt unknown
- 1996-04-03 IL IL11782496A patent/IL117824A/xx not_active IP Right Cessation
- 1996-04-04 ZA ZA962711A patent/ZA962711B/xx unknown
- 1996-04-08 AR ARP960102094A patent/AR003414A1/es unknown
- 1996-04-15 TW TW085104484A patent/TW450816B/zh not_active IP Right Cessation
-
1997
- 1997-10-06 NO NO19974603A patent/NO315408B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA962711B (en) | Use of imidazol[1,2-a]pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia | |
PL322623A1 (en) | Derivatives of imidazo [1,2-a] pyridine | |
ZA928832B (en) | Local delivery of dipyridamole for the treatment of proliferative diseases | |
IL133800A0 (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders | |
HU9401317D0 (en) | Antiviral 2-ethyl - 1h imidazo (4,5-c) quinolin-4-amines | |
GB2305605B (en) | Pipecolic acid derivatives for the treatment of neurological disorders | |
EP0524946A4 (en) | Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists | |
FI92401B (fi) | Menetelmä valmistaa farmakologisesti arvokasta pyrrolo/3,2,1-jk//1,4/bentsodiatsepiinijohdannaista | |
EP1027054A4 (en) | LOCAL CONTRIBUTION OF PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION | |
HK1040905B (zh) | 噠嗪並(4,5-b)吲哚-1-乙酰胺衍生物在製備用於治療與周圍神經受體苯並二氮雜䓬的失調有關的疾病的藥物中的用途 | |
IL92078A0 (en) | Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism | |
HK1036274A1 (en) | Imidazo (1,2-a) pyridine derivatives for the treatment of gastrointestinal diseases | |
EP0577023A3 (en) | Angiotensin-ii receptor-antagonists for the treatment of arrhythmices | |
EP0554098A3 (en) | Process for the preparation of imidazo 4,5-b pyridine derivatives | |
HUP9901258A3 (en) | Imidazo[2,1-b]thiazole and thiazolo[3,2-a]pyrimidine derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
EP0436831A3 (en) | Imidazo(1,2-a)pyridinylalkyl compounds for treatment of neurotoxic injury | |
FI98816B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroimidatso [4,5,1-jk][1,4]bentsodiatsepin-2-oni ja -2-tionijohdannaisten valmistamiseksi | |
ZA893606B (en) | Use of diazepinones for treating disorders of the microcirculation | |
AU595776B3 (en) | Therapeutic device for male sexual dysfunction | |
ZA985818B (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders. | |
ZA886511B (en) | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | |
ZA937604B (en) | 3,3-disubstituted tri and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders | |
IE893261L (en) | PYRROLO (1,2-a) IMIDAZOLES AND IMIDAZO (1,2-a) PYRIDINES | |
BG96767A (en) | Method for the preparation of an antitumour medicament | |
CS397691A3 (en) | Pyrrolo(1,2-a)imidazole and pyrrolo(1,2-a)pyridine derivatives and theiruse as 5-lipoxygenase pathway inhibitors |